healthcare giant

Abbott Laboratories declared its 409th consecutive quarterly dividend, showcasing over a century of consistent financial strength and dedication to shareholders. This enduring payout reflects a robust healthcare portfolio across medical devices, diagnostics, nutrition, and pharmaceuticals, supported by innovation and market leadership. Abbott’s dividend policy signals confidence in its business model and sustained profitability, making it a reliable investment and a key indicator in the healthcare sector.